期刊文献+

3.0 T磁共振IDEAL-IQ技术定量评估脂肪肝的价值 被引量:14

Value of fatty liver disease by 3.0 T magnetic resonance IDEAL-IQ sequence:A quantitative assessment
原文传递
导出
摘要 目的 利用3.0 T磁共振IDEAL-IQ技术探讨定量评估肝脏脂肪含量的诊断价值.方法 回顾性分析广州中医药大学第二临床医学院大学城医院2015年5月至2015年12月行3.0 T磁共振IDEAL-IQ技术扫描的病例46例,定量测量肝脏脂肪含量,并进行分度.结果 MR诊断脂肪肝41例(89.1%),脂肪肝分度:轻度23例(23/41,56.2%),轻-中度5例(5/41,12.2%),中度11例(11/41,26.8%),中-重度1例(1/41,2.4%),重度1例(1/41,2.4%).结论 3.0 T磁共振IDEAL-IQ技术是可以定量评估肝脏脂肪含量的无创手段,为临床脂肪肝的早期诊断、疾病评估和疗效评估提供有力手段. Objective To determine the diagnostic value of quantitative assessment of liver fat content by 3.0 T magnetic resonance IDEAL-IQ sequence. Methods The clinical data of 46 patients,who underwent 3.0 T magnetic resonance IDEAL-IQ sequence in the University Hospital of Second Clinical Medical College,Guangzhou University of Traditional Chinese Medicine between August 2016 and January 2017,were retrospectively analyzed. The liver fat content was determined by quantitative assessment,and classified. Results There were 41 cases of fatty liver(89.1%)by MR diagnosis,fatty liver classification:23 mild(23/41,56.2%),5 mild to moderate(5/41,12.2%),11 moderate(11/41,26.8%),1 moderate to severe (1/41,2.4%),and 1 severe (1/41,2.4%). Conclusion 3.0 T magnetic resonance IDEAL-IQ sequence is a noninvasive means for quantitative assessment of liver fat content,providing a powerful means for early diagnosis,disease evaluation and effect evaluation of fatty liver in the clinical settings.
出处 《中华生物医学工程杂志》 CAS 2017年第1期55-58,共4页 Chinese Journal of Biomedical Engineering
关键词 磁共振成像 脂肪肝 诊断 IDEAL-IQ技术 Magnetic resonance imaging Fatty liver Diagnosis IDEAL-IQ sequence
  • 相关文献

参考文献4

二级参考文献16

  • 1Fan, Jian-Gao,Peng, Yong-De.Metabolic syndrome and non-alcoholic fatty liver disease:Asian definitions and Asian studies[J].Hepatobiliary & Pancreatic Diseases International,2007,6(6):572-578. 被引量:42
  • 2范建高.糖尿病与肝病的关系及其诊治对策[J].中华糖尿病杂志,2009,1(4). 被引量:30
  • 3范建高 曾民德 等.上海市4009名机关职员脂肪肝流行病学调查[J].中华肝脏病杂志,1998,6(1):17-17.
  • 4Clark JM, Diehl AM. Defining nonalcoholic fatty liver disease: Implications for epidemiologic studies. Gastroenterology, 2003, 124:248-250.
  • 5Sanyal AJ. AGA technical review on nonalcoholic fatty liver disease.Gastroenterology, 2002, 123: 1705-1725.
  • 6Vong S, Bell BP. Chronic liver disease mortality in the United States, 1990-1998. Hepatology, 2004, 39: 476-483.
  • 7Bellentani S, Saccoccio G, Masutti F, et al. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med,2000, 132: 112-117.
  • 8Omagari K, Kadokawa Y, Masuda J, et al. Fatty liver in non-alcoholic non-overweight Japanese adults: incidence and clinical characteristics. J Gastroenterol Hepatol, 2002, 17:1098-1105.
  • 9范建高,曾民德,李继强,沈镭,陈政绩,罗国豪,刘天舒.脂肪肝的危险因素分析[J].中华预防医学杂志,1998,32(3):189-189. 被引量:57
  • 10范建高,曾民德,陈政绩,范竹萍,沈镭,李继强,邱德凯.265例脂肪肝患者病因及其特点分析[J].上海医学,1998,21(2):68-70. 被引量:103

共引文献2815

同被引文献91

引证文献14

二级引证文献59

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部